Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 22893 [05-8780]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
determined by the Freedom of
Information officials of DHHS or by a
court, data contained in the portions of
an application which have been
specifically identified by page number,
paragraph, etc., by the applicant as
containing restricted and/or proprietary
information shall not be used or
disclosed except for evaluation
purposes.
Dated: April 26, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–8819 Filed 5–2–05; 8:45 am]
BILLING CODE 4160–01–S
LaVerne Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8780 Filed 5–2–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–M
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Pub. L. 92–463, notice is
hereby given of the seventh meeting of
the Secretary’s Advisory Committee on
Genetics, Health, and Society
(SACGHS), U.S. Public Health Service.
The meeting will be held from 8:30 a.m.
to 5:30 p.m. on June 15, 2005 and 8:30
a.m. to 5:30 p.m. on June 16, 2005 at the
Bethesda North Marriott Hotel, 5701
Marinelli Road, North Bethesda,
Maryland. The meeting will be open to
the public with attendance limited to
space available. The meeting will be
Webcast.
The topics of the first day are
expected to be genetic discrimination,
direct-to-consumer marketing of genetic
tests, and coverage and reimbursement
of genetic tests and services. The
Committee aims to finalize a report on
coverage and reimbursement of genetic
tests and services after considering
public comments. The topics for the
second day are expected to include large
population studies of gene-environment
interactions and pharmacogenomics.
Time will be provided each day for
public comments.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
technologies and, as warranted, to
provide advice on these issues. The
draft meeting agenda and other
information about SACGHS, including
information about access to the
Webcast, will be available at the
VerDate jul<14>2003
15:43 May 02, 2005
Jkt 205001
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
The Committee would welcome
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment or who plan to attend the
meeting and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone
at 301–496–9838 or e-mail at
sc112c@nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
22893
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS.)
Dated: April 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8779 Filed 5–2–05; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Meeting
National Institutes of Health
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Directors
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
National Center for Research
Resources; Notice of Closed Meeting
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: May 26, 2005.
Time: 3 p.m. to 5 p.m.
Agenda: Opening remarks; approval of
minutes February 28–March 1, 2005 DCLG
meeting; NCI Director’s Remarks; reports
from NCI Listens and Learns Working
Groups: Operations Working Group, Summit
Working Group, Promotions Working Group,
and Evaluation Working Group; DCLG
recommendations on the Progress Review
Group Process; public comment; next steps.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Nancy Caliman, Executive
Secretary, Office of Liaison Activities,
National Institutes of Health, National Cancer
Institutes, 6116 Executive Boulevard, Suite
220, MS8324, Bethesda, MD 20892, (301)
496–0307, calimann@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: May 6, 2005.
Time: 11:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Barbara J. Nelson, PhD.,
Scientific Review Administrator, Office of
Review, National Center for Research
Resources, NIH, 6701 Democracy Blvd, Room
1080, 1 Democracy Plaza, Bethesda, MD
20892, (301) 435–0806.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\03MYN1.SGM
03MYN1
]]>Agencies
[Federal Register Volume 70, Number 84 (Tuesday, May 3, 2005)]
[Notices]
[Page 22893]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8780]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Pub. L. 92-463, notice is hereby given of the seventh
meeting of the Secretary's Advisory Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health Service. The meeting will be held
from 8:30 a.m. to 5:30 p.m. on June 15, 2005 and 8:30 a.m. to 5:30 p.m.
on June 16, 2005 at the Bethesda North Marriott Hotel, 5701 Marinelli
Road, North Bethesda, Maryland. The meeting will be open to the public
with attendance limited to space available. The meeting will be
Webcast.
The topics of the first day are expected to be genetic
discrimination, direct-to-consumer marketing of genetic tests, and
coverage and reimbursement of genetic tests and services. The Committee
aims to finalize a report on coverage and reimbursement of genetic
tests and services after considering public comments. The topics for
the second day are expected to include large population studies of
gene-environment interactions and pharmacogenomics. Time will be
provided each day for public comments.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic technologies and, as warranted, to
provide advice on these issues. The draft meeting agenda and other
information about SACGHS, including information about access to the
Webcast, will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
The Committee would welcome hearing from anyone wishing to provide
public comment on any issue related to genetics, health and society.
Individuals who would like to provide public comment or who plan to
attend the meeting and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at 301-496-
9838 or e-mail at sc112c@nih.gov. The SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda, MD 20892.
LaVerne Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-8780 Filed 5-2-05; 8:45 am]
BILLING CODE 4140-01-M
